Arthritis Research & Therapy (Feb 2023)
Correction: Efficacy and safety of guselkumab and adalimumab for pustulotic arthro-osteitis and their impact on peripheral blood immunophenotypes
Abstract
No abstracts available.
Arthritis Research & Therapy (Feb 2023)